• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同奥氮平口腔崩解片配方崩解时间的体外分析:初步报告。

An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.

机构信息

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA,

出版信息

Drugs R D. 2013 Dec;13(4):281-8. doi: 10.1007/s40268-013-0030-8.

DOI:10.1007/s40268-013-0030-8
PMID:24170256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3879822/
Abstract

BACKGROUND

Orodispersible tablets (ODTs) are tablet or wafer forms of medication that disintegrate in the mouth, aided only by saliva. ODTs rely on different fast dissolve/disintegration manufacturing technologies.

OBJECTIVES

Disintegration time differences for several olanzapine ODT forms were investigated. Risperdal M-Tab(®) was included as a non-olanzapine ODT comparator.

RESEARCH DESIGN AND METHODS

Eleven olanzapine ODT examples and orodispersible risperidone strengths were evaluated in vitro for formulation composition, manufacturing method, disintegration and dissolution characteristics, and formulation differences in comparison with freeze dried Zydis(®) ODT. Automated dissolution test equipment captured ODT dissolution rates by measuring real-time release of active ingredient. A high-speed video camera was used to capture tablet disintegration times in warm simulated saliva.

MAIN OUTCOME MEASURE

The main outcome measure was the disintegration and dissolution characteristics of the ODT formulations.

RESULTS

The ODT manufacturing method was associated with time to disintegrate; the fastest were freeze dried tablets, followed by soft compressed tablets and then hard/dense tablets. Olanzapine Zydis(®) was the only ODT that completely disintegrated in less than 4 s for all strengths (5, 10, 15, and 20 mg), followed by 5-mg Prolanz FAST(®) (12 s) and then risperidone ODT 4 mg (40 s). Reasons for slow dissolution of the olanzapine generics may include low product potency, excipient binding, excipient solubility, active ingredient particle size and incomplete disintegration.

CONCLUSIONS

Differences in the formulation and manufacturing process of olanzapine ODTs appear to have a strong influence on the disintegration time of the active compound; differences that may potentially impact their use in clinical practice.

摘要

背景

口崩片(ODTs)是指在口腔中崩解的片剂或薄片面剂,仅靠唾液就能帮助崩解。ODTs 依赖于不同的快速溶解/崩解制造技术。

目的

研究了几种奥氮平 ODT 形式的崩解时间差异。利培酮 M-Tab(®)作为非奥氮平 ODT 对照物被纳入研究。

研究设计和方法

对 11 种奥氮平 ODT 样本和速溶利培酮制剂进行了体外评估,评估内容包括配方组成、制造方法、崩解和溶解特性,以及与冻干 Zydis(®)ODT 的配方差异。自动溶解测试设备通过实时测量活性成分的释放来捕捉 ODT 溶解速率。高速摄像机用于在温暖的模拟唾液中捕捉片剂崩解时间。

主要观察指标

主要观察指标是 ODT 配方的崩解和溶解特性。

结果

ODT 的制造方法与崩解时间有关;崩解最快的是冻干片剂,其次是软压片剂,然后是硬片剂。奥氮平 Zydis(®)是唯一一种所有规格(5、10、15 和 20mg)在 4 秒内完全崩解的 ODT,其次是 5mg Prolanz FAST(®)(12 秒),然后是利培酮 ODT 4mg(40 秒)。奥氮平仿制药溶解缓慢的原因可能包括产品效力低、赋形剂结合、赋形剂溶解度、活性成分粒径和不完全崩解。

结论

奥氮平 ODT 的配方和制造工艺差异似乎对活性化合物的崩解时间有很强的影响;这些差异可能会对它们在临床实践中的应用产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e5/4238147/1ed664ede0f2/40268_2013_30_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e5/4238147/8c4955ee8d32/40268_2013_30_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e5/4238147/1ed664ede0f2/40268_2013_30_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e5/4238147/8c4955ee8d32/40268_2013_30_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4e5/4238147/1ed664ede0f2/40268_2013_30_Fig2_HTML.jpg

相似文献

1
An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.不同奥氮平口腔崩解片配方崩解时间的体外分析:初步报告。
Drugs R D. 2013 Dec;13(4):281-8. doi: 10.1007/s40268-013-0030-8.
2
Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.双氯芬酸掩味口腔崩解片制剂的设计、开发及体外评价
Drug Dev Ind Pharm. 2015 Apr;41(4):540-51. doi: 10.3109/03639045.2014.884122. Epub 2014 Feb 5.
3
Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.直接压片法制备氯氮平口腔崩解片的处方设计与评价
Pharmazie. 2013 Feb;68(2):110-6.
4
Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.两种用于口腔崩解片和迷你片直接压片的新型共处理辅料的评价。
Eur J Pharm Biopharm. 2021 Nov;168:122-130. doi: 10.1016/j.ejpb.2021.08.016. Epub 2021 Aug 30.
5
A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation.氯唑沙宗口腔崩解片的药学研究:处方、体外及体内评价
Drug Deliv. 2016 Oct;23(8):2998-3007. doi: 10.3109/10717544.2016.1138340. Epub 2016 Feb 1.
6
Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.加工方法对木糖醇-淀粉基共处理赋形剂用于口腔崩解片应用的影响。
Pak J Pharm Sci. 2020 Mar;33(2):551-559.
7
Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.冷冻干燥法制备纳米晶体吡罗昔康口崩片的制剂策略与评价。
Int J Pharm. 2014 Jun 5;467(1-2):27-33. doi: 10.1016/j.ijpharm.2014.03.047. Epub 2014 Mar 26.
8
Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone.共处理辅料类型对含卡托普利、曲马多和多潘立酮的口腔崩解片性质的影响。
Int J Pharm. 2023 Apr 5;636:122838. doi: 10.1016/j.ijpharm.2023.122838. Epub 2023 Mar 13.
9
[Pharmaceutical formulations and adherence to pharmacological treatment in psychiatry: the example of oral disintegrating tablet of olanzapine].[精神科的药物制剂与药物治疗依从性:以奥氮平口腔崩解片为例]
Riv Psichiatr. 2012 Jan-Feb;47(1):30-9. doi: 10.1708/1034.11289.
10
Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.Prosolv和Prosolv:甘露醇200直接压片填充剂对阿托伐他汀口腔崩解片物理机械性能的影响。
Pharm Dev Technol. 2015 Jun;20(4):394-400. doi: 10.3109/10837450.2013.871031. Epub 2014 Jan 8.

引用本文的文献

1
Evaluation and Comparison of Three Types of Spray Dried Coprocessed Excipient Avicel® for Direct Compression.三种喷雾干燥共处理辅料 Avicel® 直接压片的评价与比较。
Biomed Res Int. 2018 Apr 19;2018:2739428. doi: 10.1155/2018/2739428. eCollection 2018.

本文引用的文献

1
Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.一项多中心、随机、交叉研究比较了奥氮平口崩片与普通口服片剂在患者中的偏好。
World J Biol Psychiatry. 2010 Oct;11(7):894-903. doi: 10.3109/15622975.2010.505663.
2
A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.一项关于舌下含服奥氮平口崩片与口服奥氮平对体重指数影响的随机对照试验:鸭嘴兽研究
Schizophr Res. 2009 Aug;113(1):41-8. doi: 10.1016/j.schres.2009.05.024. Epub 2009 Jun 16.
3
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.
第二代与第一代抗精神病药物治疗精神分裂症的荟萃分析。
Lancet. 2009 Jan 3;373(9657):31-41. doi: 10.1016/S0140-6736(08)61764-X. Epub 2008 Dec 6.
4
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.第二代抗精神病药物治疗精神分裂症的头对头比较的荟萃分析。
Am J Psychiatry. 2009 Feb;166(2):152-63. doi: 10.1176/appi.ajp.2008.08030368. Epub 2008 Nov 17.
5
Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.精神分裂症的长期抗精神病药物单一疗法:一项泛大陆观察性研究中接受奥氮平、喹硫平、利培酮或氟哌啶醇单一疗法治疗的患者的疾病负担及比较结果
J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9.
6
About a synthetic saliva for in vitro studies.关于一种用于体外研究的合成唾液。
Talanta. 2001 Mar 16;53(6):1103-15. doi: 10.1016/s0039-9140(00)00618-4.
7
Olanzapine orally disintegrating tablet: a review of efficacy and compliance.奥氮平口腔崩解片:疗效与依从性综述
CNS Neurosci Ther. 2008 Fall;14(3):203-14. doi: 10.1111/j.1755-5949.2008.00053.x.
8
Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.慢性精神分裂症患者自知力与药物治疗态度及临床结局之间的横断面和纵向关系。
Schizophr Bull. 2009 Mar;35(2):336-46. doi: 10.1093/schbul/sbn067. Epub 2008 Jun 26.
9
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.抗精神病药物在首发精神分裂症和分裂样障碍中的疗效:一项开放性随机临床试验。
Lancet. 2008 Mar 29;371(9618):1085-97. doi: 10.1016/S0140-6736(08)60486-9.
10
Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.门诊环境中的抗精神病药物处方模式:洲际精神分裂症门诊健康结局(IC-SOHO)研究的24个月结果。
Eur Neuropsychopharmacol. 2008 Mar;18(3):170-80. doi: 10.1016/j.euroneuro.2007.08.001. Epub 2007 Sep 19.